Prognostic factors in surgical resection of sacral chordoma

Andrea Angelini, Elisa Pala, Teresa Calabrò, Marco Maraldi, Pietro Ruggieri

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background and objectives The best treatment of sacral chordoma is surgical resection, nowadays associated with optimized radiation therapy. We analysed 1) the oncologic outcome in a large series; 2) the effect of previous intralesional surgery, resection level, tumor volume and margins on survivorship to local recurrence (LR) and 3) the complication rate. Methods We reviewed 71 patients with sacral chordomas. Forty-eight resections were proximal to S3. Mean tumor volume was 535 cm3. Eleven received previous intralesional surgery elsewhere. Margins were wide in 44 resections, wide-contaminated in 11, marginal in 9 and intralesional in 7. Results Overall survival was 92%, 65% and 44% at 5, 10 and 15 years. At a mean of 9.5 years 37 were NED (54.4%), 23 died with disease (33.8%) and 8 were alive with disease (11.7%). Relapses included 15 LRs, 6 distant metastases, 17 both. LR rate was significantly higher in patients with previous surgery (p=0.0217), with inadequate margins (p= 0.0339) and large tumors(p

Original languageEnglish
Pages (from-to)344-351
Number of pages8
JournalJournal of Surgical Oncology
Volume112
Issue number4
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Chordoma
Tumor Burden
Recurrence
Radiotherapy
Survival Rate
Neoplasm Metastasis
Survival
Neoplasms
Therapeutics

Keywords

  • chordoma
  • prognostic factors
  • resection
  • sacral surgery
  • sacrum
  • tumor

ASJC Scopus subject areas

  • Surgery
  • Oncology
  • Medicine(all)

Cite this

Angelini, A., Pala, E., Calabrò, T., Maraldi, M., & Ruggieri, P. (2015). Prognostic factors in surgical resection of sacral chordoma. Journal of Surgical Oncology, 112(4), 344-351. https://doi.org/10.1002/jso.23987

Prognostic factors in surgical resection of sacral chordoma. / Angelini, Andrea; Pala, Elisa; Calabrò, Teresa; Maraldi, Marco; Ruggieri, Pietro.

In: Journal of Surgical Oncology, Vol. 112, No. 4, 01.09.2015, p. 344-351.

Research output: Contribution to journalArticle

Angelini, A, Pala, E, Calabrò, T, Maraldi, M & Ruggieri, P 2015, 'Prognostic factors in surgical resection of sacral chordoma', Journal of Surgical Oncology, vol. 112, no. 4, pp. 344-351. https://doi.org/10.1002/jso.23987
Angelini A, Pala E, Calabrò T, Maraldi M, Ruggieri P. Prognostic factors in surgical resection of sacral chordoma. Journal of Surgical Oncology. 2015 Sep 1;112(4):344-351. https://doi.org/10.1002/jso.23987
Angelini, Andrea ; Pala, Elisa ; Calabrò, Teresa ; Maraldi, Marco ; Ruggieri, Pietro. / Prognostic factors in surgical resection of sacral chordoma. In: Journal of Surgical Oncology. 2015 ; Vol. 112, No. 4. pp. 344-351.
@article{cee6fef03d264c9192c2e178a6727e75,
title = "Prognostic factors in surgical resection of sacral chordoma",
abstract = "Background and objectives The best treatment of sacral chordoma is surgical resection, nowadays associated with optimized radiation therapy. We analysed 1) the oncologic outcome in a large series; 2) the effect of previous intralesional surgery, resection level, tumor volume and margins on survivorship to local recurrence (LR) and 3) the complication rate. Methods We reviewed 71 patients with sacral chordomas. Forty-eight resections were proximal to S3. Mean tumor volume was 535 cm3. Eleven received previous intralesional surgery elsewhere. Margins were wide in 44 resections, wide-contaminated in 11, marginal in 9 and intralesional in 7. Results Overall survival was 92{\%}, 65{\%} and 44{\%} at 5, 10 and 15 years. At a mean of 9.5 years 37 were NED (54.4{\%}), 23 died with disease (33.8{\%}) and 8 were alive with disease (11.7{\%}). Relapses included 15 LRs, 6 distant metastases, 17 both. LR rate was significantly higher in patients with previous surgery (p=0.0217), with inadequate margins (p= 0.0339) and large tumors(p",
keywords = "chordoma, prognostic factors, resection, sacral surgery, sacrum, tumor",
author = "Andrea Angelini and Elisa Pala and Teresa Calabr{\`o} and Marco Maraldi and Pietro Ruggieri",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/jso.23987",
language = "English",
volume = "112",
pages = "344--351",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Prognostic factors in surgical resection of sacral chordoma

AU - Angelini, Andrea

AU - Pala, Elisa

AU - Calabrò, Teresa

AU - Maraldi, Marco

AU - Ruggieri, Pietro

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background and objectives The best treatment of sacral chordoma is surgical resection, nowadays associated with optimized radiation therapy. We analysed 1) the oncologic outcome in a large series; 2) the effect of previous intralesional surgery, resection level, tumor volume and margins on survivorship to local recurrence (LR) and 3) the complication rate. Methods We reviewed 71 patients with sacral chordomas. Forty-eight resections were proximal to S3. Mean tumor volume was 535 cm3. Eleven received previous intralesional surgery elsewhere. Margins were wide in 44 resections, wide-contaminated in 11, marginal in 9 and intralesional in 7. Results Overall survival was 92%, 65% and 44% at 5, 10 and 15 years. At a mean of 9.5 years 37 were NED (54.4%), 23 died with disease (33.8%) and 8 were alive with disease (11.7%). Relapses included 15 LRs, 6 distant metastases, 17 both. LR rate was significantly higher in patients with previous surgery (p=0.0217), with inadequate margins (p= 0.0339) and large tumors(p

AB - Background and objectives The best treatment of sacral chordoma is surgical resection, nowadays associated with optimized radiation therapy. We analysed 1) the oncologic outcome in a large series; 2) the effect of previous intralesional surgery, resection level, tumor volume and margins on survivorship to local recurrence (LR) and 3) the complication rate. Methods We reviewed 71 patients with sacral chordomas. Forty-eight resections were proximal to S3. Mean tumor volume was 535 cm3. Eleven received previous intralesional surgery elsewhere. Margins were wide in 44 resections, wide-contaminated in 11, marginal in 9 and intralesional in 7. Results Overall survival was 92%, 65% and 44% at 5, 10 and 15 years. At a mean of 9.5 years 37 were NED (54.4%), 23 died with disease (33.8%) and 8 were alive with disease (11.7%). Relapses included 15 LRs, 6 distant metastases, 17 both. LR rate was significantly higher in patients with previous surgery (p=0.0217), with inadequate margins (p= 0.0339) and large tumors(p

KW - chordoma

KW - prognostic factors

KW - resection

KW - sacral surgery

KW - sacrum

KW - tumor

UR - http://www.scopus.com/inward/record.url?scp=84942297693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942297693&partnerID=8YFLogxK

U2 - 10.1002/jso.23987

DO - 10.1002/jso.23987

M3 - Article

VL - 112

SP - 344

EP - 351

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -